On September 4, 2024, community partners gathered for a retreat on Hep B and C advocacy in NYC, hosted by the Hep Free NYC Advocacy Committee. Twenty-seven people participated in-person and virtually in advocacy capacity building exercises, a Strengths, Problems, Weaknesses, and Threats (SPOT) analysis of existing Hep B and C advocacy efforts, and goal setting for 2025.
Last Updated on January 15, 2025 by HepFree NYC
Participants described psychological and behavioral transformation over the course of HCV treatment. These included reductions in internalized stigma and shame related to HCV and addiction, increases in HCV disclosure and self-care, reductions in substance use, and new desire to ...
The USPSTF's draft recommendations on testing hepatitis C among injection drug users and others at high risk is a major improvement over previous guidelines (a grade “B”, meaning testing is recommended).
The Hepatitis A, B and C in NYC: 2022 Annual Report provides the latest surveillance and programmatic data on viral hepatitis in NYC.
The Council of the City of New York Proclamation Whereas: Hepatitis B is a silent epidemic that affects 1.2 million Americans, most of whom do not know they are infected with the virus. Chronic hepatitis B can damage the liver for up to 20-30 years without symptoms, and can lead ...
Patient Health Perspectives is looking for people who have been diagnosed with hepatitis C who are interested in sharing their story in a video which will be used to educate others about the HCV patient experience.
An Academy Award winning director is seeking Hep C patients for a web documentary film about Hep C and the challenges related to living with the disease.
“Have you been diagnosed with Hepatitis C? Are you a Baby Boomer – born between 1945 – 1965, and uncertain about your diagnosis? Do you write and understand English?”
DA approved revisions to the Olysio (simeprevir) label to include dosing recommendations for the treatment of HCV/HIV-1 coinfection and to expand the indications and usage to include genotype 4 infection.
